Kanai K et al. |
Effect of prostaglandin D2 on VEGF release by nasal polyp fibroblasts. |
2016 |
Allergol Int |
pmid:27091669
|
Akabane H et al. |
Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells. |
2006 |
Allergol Int |
pmid:17130681
|
Ishimura M et al. |
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. |
2006 |
Allergol Int |
pmid:17130683
|
Yoshimura T et al. |
Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. |
2008 |
Allergol Int |
pmid:18797183
|
Horak F et al. |
Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. |
1998 |
Allergy |
pmid:9491231
|
Howarth PH |
Mediators of nasal blockage in allergic rhinitis. |
1997 |
Allergy |
pmid:9353555
|
Abdelaziz MM et al. |
The potential of active metabolites of antihistamines in the management of allergic disease. |
2000 |
Allergy |
pmid:10843422
|
Ito W et al. |
Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. |
2007 |
Allergy |
pmid:17362253
|
Holgate ST et al. |
The contribution of mast cell mediators to acute allergic reactions in human skin and airways. |
1988 |
Allergy |
pmid:2451448
|
Wang XS et al. |
PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease. |
2007 |
Allergy |
pmid:17508965
|
Church MM et al. |
The mediator and cellular basis of the allergic response. |
1988 |
Allergy |
pmid:2462372
|
Okayama Y et al. |
In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. |
1994 |
Allergy |
pmid:7518654
|
Gulliksson M et al. |
Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. |
2006 |
Allergy |
pmid:17073880
|
Takafuji S et al. |
Release of granule proteins from human eosinophils stimulated with mast-cell mediators. |
1998 |
Allergy |
pmid:9821474
|
Pérez-Novo CA et al. |
CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. |
2010 |
Allergy |
pmid:19839971
|
Ono E et al. |
Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite. |
2008 |
Allergy |
pmid:18315738
|
Campbell AM et al. |
Modulation of eicosanoid and histamine release from human dispersed lung cells by terfenadine. |
1993 |
Allergy |
pmid:7681268
|
Guyer BJ et al. |
Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis. |
2006 May-Jun |
Allergy Asthma Proc |
pmid:16913263
|
Naclerio RM |
Additional properties of cetirizine, a new H1 antagonist. |
1991 May-Jun |
Allergy Proc |
pmid:1680095
|
Nishino S et al. |
Salivary prostaglandin concentrations: possible state indicators for major depression. |
1989 |
Am J Psychiatry |
pmid:2627202
|
Okano M et al. |
Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. |
2006 May-Jun |
Am J Rhinol |
pmid:16871941
|
Paolini JF et al. |
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. |
2008 |
Am. J. Cardiol. |
pmid:18308010
|
Song HH et al. |
Anti-inflammatory and anti-allergic effect of Agaricus blazei extract in bone marrow-derived mast cells. |
2012 |
Am. J. Chin. Med. |
pmid:22928836
|
Kawabe Y et al. |
Genesis and recovery of ethanol-induced gastric lesions in rats: possible involvement of prostaglandin D2. |
1989 |
Am. J. Gastroenterol. |
pmid:2916522
|
Fitscha P et al. |
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. |
1985 |
Am. J. Hematol. |
pmid:3885723
|
Sinzinger H et al. |
Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. |
1991 |
Am. J. Hematol. |
pmid:1899965
|
Wasserman SI |
The mast cell and theophylline in asthma. |
1985 |
Am. J. Med. |
pmid:3002176
|
Ruano D et al. |
Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia. |
2007 |
Am. J. Med. Genet. B Neuropsychiatr. Genet. |
pmid:17230501
|
Afrin LB |
Polycythemia from mast cell activation syndrome: lessons learned. |
2011 |
Am. J. Med. Sci. |
pmid:21642812
|
Afrin LB |
Mast cell activation syndrome as a significant comorbidity in sickle cell disease. |
2014 |
Am. J. Med. Sci. |
pmid:25171546
|
Newman JH and Sheller JR |
Arachidonic acid metabolites in the healthy and diseased lung. |
1984 |
Am. J. Med. Sci. |
pmid:6091454
|
White RP et al. |
Eicosanoid levels in CSF of premature infants with posthemorrhagic hydrocephalus. |
1990 |
Am. J. Med. Sci. |
pmid:2321665
|
Zhang YF et al. |
Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense. |
2006 |
Am. J. Nephrol. |
pmid:17183189
|
Chana RS et al. |
Statins but not thiazolidinediones attenuate albumin-mediated chemokine production by proximal tubular cells independently of endocytosis. |
2008 |
Am. J. Nephrol. |
pmid:18535368
|
Zhang YJ et al. |
Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2). |
2006 |
Am. J. Nephrol. |
pmid:16864989
|
Norwitz ER and Wilson T |
Secretory component: a potential regulator of endometrial-decidual prostaglandin production in early human pregnancy. |
2000 |
Am. J. Obstet. Gynecol. |
pmid:10920317
|
Rao PS et al. |
Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses. |
1984 |
Am. J. Obstet. Gynecol. |
pmid:6424477
|
Rao PS et al. |
Dose-dependent effects of prostaglandin D2 on hemodynamics, renal function, and blood gas analyses. |
1987 |
Am. J. Obstet. Gynecol. |
pmid:3555078
|
Abelson MB et al. |
Aspirin therapy in vernal conjunctivitis. |
1983 |
Am. J. Ophthalmol. |
pmid:6573138
|
Poncin S et al. |
Oxidative stress: a required condition for thyroid cell proliferation. |
2010 |
Am. J. Pathol. |
pmid:20093493
|
Ugajin T et al. |
FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils. |
2011 |
Am. J. Pathol. |
pmid:21712025
|
Yamamoto Y et al. |
Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2. |
2011 |
Am. J. Pathol. |
pmid:21703412
|
Zamuner SR et al. |
Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2. |
2005 |
Am. J. Pathol. |
pmid:16251413
|
Jeon KI et al. |
Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation. |
2014 |
Am. J. Pathol. |
pmid:24650561
|
Yang C et al. |
Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. |
2007 |
Am. J. Pathol. |
pmid:17255338
|
Mohri I et al. |
Inhibition of prostaglandin D synthase suppresses muscular necrosis. |
2009 |
Am. J. Pathol. |
pmid:19359520
|
Marx N et al. |
Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. |
1998 |
Am. J. Pathol. |
pmid:9665460
|
Shimura C et al. |
Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. |
2010 |
Am. J. Pathol. |
pmid:20008150
|
Nakashiro KI et al. |
Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. |
2001 |
Am. J. Pathol. |
pmid:11485917
|
Poncin S et al. |
N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro. |
2010 |
Am. J. Pathol. |
pmid:20489149
|